Comparable Efficacy of Two Anticoagulant Strategies Following Total Hip Replacement in Elderly Patients: A Prospective Randomised Controlled Trial.

TL;DR

In elderly patients undergoing hip replacement, concurrent aspirin plus low-molecular-weight heparin (LMWH) reduced blood clot occurrence to 16% versus 30% with sequential LMWH alone, without increasing bleeding risk . This is a single RCT from one center, so findings require confirmation in larger studies before changing clinical practice.

What the Study Found

Venous thromboembolism (VTE) represents a serious postoperative complication after total hip replacement, particularly in older adults. Blood clots can form in leg veins during the immobility and hypercoagulable state following major orthopedic surgery, potentially leading to pulmonary embolism. Current anticoagulation strategies aim to prevent clot formation while minimizing surgical bleeding, creating a clinical balance that remains contested across different surgical centers.

Researchers in Shanghai randomized 196 elderly patients undergoing hip replacement into two anticoagulation groups. The combination therapy group (n=99) received aspirin started immediately after surgery, continuing concurrently with low-molecular-weight heparin. The sequential therapy group (n=97) received LMWH alone, with aspirin introduced only after heparin was discontinued. This design allowed direct comparison of timing and combination strategy rather than comparing aspirin versus heparin in isolation.

The combination approach showed clinical advantages at 30 days post-surgery. VTE incidence dropped to 16.1% in the aspirin-plus-LMWH group compared to 29.8% in the sequential LMWH-only group (p<0.05). The researchers observed this difference emerged over the month following surgery, with some separation already visible at the 7-day timepoint. Critically, this improved VTE reduction did not come at the cost of increased bleeding complications. Intraoperative blood loss, blood transfusion volume, and postoperative hemoglobin levels showed no significant differences between groups, suggesting the dual-agent approach did not translate into greater perioperative hemorrhage.

The mechanism proposed by the authors centers on surgery-induced hypercoagulability: the body's exaggerated clotting response to trauma. Aspirin reduces platelet aggregation through cyclooxygenase inhibition, while LMWH antagonizes the coagulation cascade through factor Xa inhibition. By targeting these two distinct pathological pathways simultaneously rather than sequentially, concurrent administration may provide more robust suppression of the hypercoagulable state during the highest-risk postoperative period.

What This Means for You

This finding applies narrowly to older adults undergoing hip replacement surgery in hospital settings, not to general population use of aspirin or anticoagulants. The result suggests that orthopedic surgeons managing elderly hip replacement patients may achieve better clot prevention by starting aspirin concurrently with LMWH rather than waiting until heparin is stopped. The lack of increased bleeding risk removes a primary safety concern that might otherwise limit adoption.

However, several limitations constrain interpretation. This is a single-center trial from China with 196 total participants, moderate by modern RCT standards. The 30-day VTE difference of 13.7 percentage points is substantial clinically but represents a single measurement at one timepoint. Longer follow-up data beyond 30 days, bleeding events specifically at different severity levels, and outcomes in other populations remain unknown. The study did not assess symptomatic versus asymptomatic clots, which matters considerably for clinical significance.

The findings cannot be extrapolated to younger patients, different surgical procedures, or patients with contraindications to dual anticoagulation such as active bleeding or severe thrombocytopenia. Individual patient factors would determine applicability, as would institutional protocols and surgeon preference.

Study Details

Sources

Comparable Efficacy of Two Anticoagulant Strategies Following Total Hip Replacement in Elderly Patients: A Prospective Randomised Controlled Trial. Journal of the College of Physicians and Surgeons--Pakistan. PubMed ID: 42403128